{"name":"ACCORD","slug":"accord","ticker":"","exchange":"","domain":"accord.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":300000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Jevtana Kit","genericName":"cabazitaxel","slug":"cabazitaxel","revenue":300000000,"yoyGrowth":0,"percentOfTotal":100}],"timeline":[{"date":"1985-01-01","label":"Lupron first approved","drug":"Lupron","drugSlug":"leuprolide","type":"approval","sentiment":"positive"},{"date":"1985-01-01","label":"Lupron first approved","drug":"Lupron","drugSlug":"leuprorelin","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Gemzar first approved","drug":"Gemzar","drugSlug":"gemcitabine-hydrochloride","type":"approval","sentiment":"positive"},{"date":"1996-01-01","label":"Gemzar first approved","drug":"Gemzar","drugSlug":"gemcitabine","type":"approval","sentiment":"positive"},{"date":"2010-01-01","label":"Jevtana Kit first approved","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"approval","sentiment":"positive"},{"date":"2026-06-10","label":"Jevtana Kit patent expiry (Compound)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2030-06-28","label":"Gemzar patent expiry (Formulation)","drug":"Gemzar","drugSlug":"gemcitabine-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2030-10-27","label":"Jevtana Kit patent expiry (Method of Use)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2030-10-27","label":"Jevtana Kit patent expiry (Method of Use)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2030-10-27","label":"Jevtana Kit patent expiry (Method of Use)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2030-10-27","label":"Jevtana Kit patent expiry (Method of Use)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2031-04-27","label":"Jevtana Kit patent expiry (Compound)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2031-04-27","label":"Jevtana Kit patent expiry (Compound)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2031-04-27","label":"Jevtana Kit patent expiry (Compound)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2031-04-27","label":"Jevtana Kit patent expiry (Compound)","drug":"Jevtana Kit","drugSlug":"cabazitaxel","type":"patent_expiry","sentiment":"negative"},{"date":"2032-04-15","label":"Gemzar patent expiry (Formulation)","drug":"Gemzar","drugSlug":"gemcitabine-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2033-07-01","label":"Gemzar patent expiry (Formulation)","drug":"Gemzar","drugSlug":"gemcitabine-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-19","label":"Gemzar patent expiry (Formulation)","drug":"Gemzar","drugSlug":"gemcitabine-hydrochloride","type":"patent_expiry","sentiment":"negative"},{"date":"2034-08-19","label":"Gemzar patent expiry (Formulation)","drug":"Gemzar","drugSlug":"gemcitabine-hydrochloride","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":300000000,"percentOfTotal":100,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Jevtana Kit","genericName":"cabazitaxel","slug":"cabazitaxel","indication":"Metastatic Prostate Carcinoma","status":"marketed","revenue":300000000},{"name":"Gemzar","genericName":"Gemcitabine Hydrochloride","slug":"gemcitabine-hydrochloride","indication":"Adenocarcinoma of pancreas","status":"marketed"},{"name":"Gemzar","genericName":"gemcitabine","slug":"gemcitabine","indication":"Adenocarcinoma of pancreas","status":"marketed"},{"name":"Lupron","genericName":"leuprolide","slug":"leuprolide","indication":"Advanced Prostatic Carcinoma","status":"marketed"},{"name":"Lupron","genericName":"leuprorelin","slug":"leuprorelin","indication":"Advanced Prostatic Carcinoma","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"HERCESSI","genericName":"TRASTUZUMAB-STRF","slug":"trastuzumab-strf","indication":"Other","status":"marketed"},{"name":"IMULDOSA","genericName":"USTEKINUMAB-SRLF","slug":"ustekinumab-srlf","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Jevtana Kit","genericName":"cabazitaxel","slug":"cabazitaxel","phase":"marketed","mechanism":"Cabazitaxel works by binding to tubulin beta, disrupting microtubule formation and preventing cancer cell division.","indications":["Metastatic Prostate Carcinoma"],"catalyst":""},{"name":"Gemzar","genericName":"Gemcitabine Hydrochloride","slug":"gemcitabine-hydrochloride","phase":"marketed","mechanism":"Gemcitabine kills cells during DNA synthesis and blocks G1/S-phase progression.","indications":["Adenocarcinoma of pancreas","Malignant tumor of ovary","Metastatic Breast Carcinoma","Non-small cell lung cancer"],"catalyst":""},{"name":"Gemzar","genericName":"gemcitabine","slug":"gemcitabine","phase":"marketed","mechanism":"Gemzar works by mimicking a building block of DNA, tricking cancer cells into incorporating it into their DNA and then stopping the replication process.","indications":["Adenocarcinoma of pancreas","Malignant tumor of ovary","Metastatic Breast Carcinoma","Non-small cell lung cancer"],"catalyst":""},{"name":"Lupron","genericName":"leuprolide","slug":"leuprolide","phase":"marketed","mechanism":"Lupron works by binding to and activating the gonadotropin-releasing hormone receptor, which ultimately leads to a decrease in the production of sex hormones.","indications":["Advanced Prostatic Carcinoma","Anemia due to Bleeding Uterine Leiomyoma","Endometriosis","Precocious puberty"],"catalyst":""},{"name":"Lupron","genericName":"leuprorelin","slug":"leuprorelin","phase":"marketed","mechanism":"Leuprolide acetate, a long-acting GnRH analog, initially stimulates then suppresses pituitary gonadotropins, reducing gonadal steroid secretion.","indications":["Advanced Prostatic Carcinoma","Anemia due to Bleeding Uterine Leiomyoma","Endometriosis","Precocious puberty"],"catalyst":""},{"name":"HERCESSI","genericName":"TRASTUZUMAB-STRF","slug":"trastuzumab-strf","phase":"marketed","mechanism":"","indications":[],"catalyst":""},{"name":"IMULDOSA","genericName":"USTEKINUMAB-SRLF","slug":"ustekinumab-srlf","phase":"marketed","mechanism":"","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"7241907","type":"Compound","expiryDate":"2025-12-10","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"7241907*PED","type":"Compound","expiryDate":"2026-06-10","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Gemzar","drugSlug":"gemcitabine-hydrochloride","patentNumber":"12403086","type":"Formulation","expiryDate":"2030-06-28","territory":"US","genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"12453712","type":"Method of Use","expiryDate":"2030-10-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"10583110","type":"Method of Use","expiryDate":"2030-10-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"10716777","type":"Method of Use","expiryDate":"2030-10-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"8927592","type":"Method of Use","expiryDate":"2030-10-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"8927592*PED","type":"Compound","expiryDate":"2031-04-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"10583110*PED","type":"Compound","expiryDate":"2031-04-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"10716777*PED","type":"Compound","expiryDate":"2031-04-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Jevtana Kit","drugSlug":"cabazitaxel","patentNumber":"12453712*PED","type":"Compound","expiryDate":"2031-04-27","territory":"US","annualRevenue":300000000,"genericFilings":[]},{"drugName":"Gemzar","drugSlug":"gemcitabine-hydrochloride","patentNumber":"8679094","type":"Formulation","expiryDate":"2032-04-15","territory":"US","genericFilings":[]},{"drugName":"Gemzar","drugSlug":"gemcitabine-hydrochloride","patentNumber":"9241948","type":"Formulation","expiryDate":"2033-07-01","territory":"US","genericFilings":[]},{"drugName":"Gemzar","drugSlug":"gemcitabine-hydrochloride","patentNumber":"10729823","type":"Formulation","expiryDate":"2034-08-19","territory":"US","genericFilings":[]},{"drugName":"Gemzar","drugSlug":"gemcitabine-hydrochloride","patentNumber":"12447241","type":"Formulation","expiryDate":"2034-08-19","territory":"US","genericFilings":[]}],"drugCount":7,"phaseCounts":{"marketed":7},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}